Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 173

1.

Cytosolic DNA Sensor Upregulation Accompanies DNA Electrotransfer in B16.F10 Melanoma Cells.

Znidar K, Bosnjak M, Cemazar M, Heller LC.

Mol Ther Nucleic Acids. 2016 Jun 7;5(6):e322. doi: 10.1038/mtna.2016.34.

PMID:
27271988
2.

European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer.

Bertino G, Sersa G, De Terlizzi F, Occhini A, Plaschke CC, Groselj A, Langdon C, Grau JJ, McCaul JA, Heuveling D, Cemazar M, Strojan P, de Bree R, Leemans CR, Wessel I, Gehl J, Benazzo M.

Eur J Cancer. 2016 Jun 4;63:41-52. doi: 10.1016/j.ejca.2016.05.001. [Epub ahead of print]

3.

Tumor radiosensitization by gene therapy against endoglin.

Stimac M, Kamensek U, Cemazar M, Kranjc S, Coer A, Sersa G.

Cancer Gene Ther. 2016 May 20. doi: 10.1038/cgt.2016.20. [Epub ahead of print]

PMID:
27199221
4.

Cytotoxic trans-platinum(II) complex with 3-hydroxymethylpyridine: Synthesis, X-ray structure and biological activity evaluation.

Grabner S, Modec B, Bukovec N, Bukovec P, Čemažar M, Kranjc S, Serša G, Sčančar J.

J Inorg Biochem. 2016 Aug;161:40-51. doi: 10.1016/j.jinorgbio.2016.04.031. Epub 2016 Apr 26.

PMID:
27189143
5.

Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patients.

Hribernik A, Cemazar M, Sersa G, Bosnjak M, Snoj M.

Radiol Oncol. 2016 Feb 16;50(1):21-7. doi: 10.1515/raon-2015-0048. eCollection 2016 Mar 1.

6.

Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review.

Campana LG, Clover AJ, Valpione S, Quaglino P, Gehl J, Kunte C, Snoj M, Cemazar M, Rossi CR, Miklavcic D, Sersa G.

Radiol Oncol. 2016 Feb 16;50(1):1-13. doi: 10.1515/raon-2016-0006. eCollection 2016 Mar 1. Review.

7.

Visualization of Nonspecific Antitumor Effectiveness and Vascular Effects of Gene Electro-Transfer to Tumors.

Kamensek U, Rols MP, Cemazar M, Golzio M.

Curr Gene Ther. 2016;16(2):90-7.

PMID:
27029945
8.

Magnetic field contributes to the cellular uptake for effective therapy with magnetofection using plasmid DNA encoding against Mcam in B16F10 melanoma in vivo.

Prosen L, Hudoklin S, Cemazar M, Stimac M, Lampreht Tratar U, Ota M, Scancar J, Romih R, Sersa G.

Nanomedicine (Lond). 2016 Mar;11(6):627-41. doi: 10.2217/nnm.16.4. Epub 2016 Mar 8.

PMID:
27021639
9.

Bleomycin pharmacokinetics of bolus bleomycin dose in elderly cancer patients treated with electrochemotherapy.

Groselj A, Krzan M, Kosjek T, Bosnjak M, Sersa G, Cemazar M.

Cancer Chemother Pharmacol. 2016 May;77(5):939-47. doi: 10.1007/s00280-016-3004-z. Epub 2016 Mar 18.

PMID:
26992379
10.

Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours.

Cemazar M, Ambrozic Avgustin J, Pavlin D, Sersa G, Poli A, Krhac Levacic A, Tesic N, Lampreht Tratar U, Rak M, Tozon N.

Vet Comp Oncol. 2016 Feb 3. doi: 10.1111/vco.12208. [Epub ahead of print]

PMID:
26840222
11.

Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects.

Dolinsek T, Sersa G, Prosen L, Bosnjak M, Stimac M, Razborsek U, Cemazar M.

Cancers (Basel). 2015 Dec 24;8(1). pii: E3. doi: 10.3390/cancers8010003.

12.

Electrochemotherapy of colorectal liver metastases--an observational study of its effects on the electrocardiogram.

Mali B, Gorjup V, Edhemovic I, Brecelj E, Cemazar M, Sersa G, Strazisar B, Miklavcic D, Jarm T.

Biomed Eng Online. 2015;14 Suppl 3:S5. doi: 10.1186/1475-925X-14-S3-S5. Epub 2015 Aug 27.

13.

Coupling treatment planning with navigation system: a new technological approach in treatment of head and neck tumors by electrochemotherapy.

Groselj A, Kos B, Cemazar M, Urbancic J, Kragelj G, Bosnjak M, Veberic B, Strojan P, Miklavcic D, Sersa G.

Biomed Eng Online. 2015;14 Suppl 3:S2. doi: 10.1186/1475-925X-14-S3-S2. Epub 2015 Aug 27.

14.

Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer.

Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, Miklavcic D.

Cancer Immunol Immunother. 2015 Oct;64(10):1315-27. doi: 10.1007/s00262-015-1724-2. Epub 2015 Jun 12. Review.

15.

Endoglin (CD105) Silencing Mediated by shRNA Under the Control of Endothelin-1 Promoter for Targeted Gene Therapy of Melanoma.

Tesic N, Kamensek U, Sersa G, Kranjc S, Stimac M, Lampreht U, Preat V, Vandermeulen G, Butinar M, Turk B, Cemazar M.

Mol Ther Nucleic Acids. 2015 May 5;4:e239. doi: 10.1038/mtna.2015.12.

PMID:
25942402
16.

Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted Effects.

Stimac M, Dolinsek T, Lampreht U, Cemazar M, Sersa G.

PLoS One. 2015 Apr 24;10(4):e0124913. doi: 10.1371/journal.pone.0124913. eCollection 2015.

17.

Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity.

Mirković B, Markelc B, Butinar M, Mitrović A, Sosič I, Gobec S, Vasiljeva O, Turk B, Čemažar M, Serša G, Kos J.

Oncotarget. 2015 Aug 7;6(22):19027-42.

18.

Gene Electrotransfer of Canine Interleukin 12 into Canine Melanoma Cell Lines.

Lampreht U, Kamensek U, Stimac M, Sersa G, Tozon N, Bosnjak M, Brozic A, de Sá Oliveira GG, Nakagawa T, Saeki K, Cemazar M.

J Membr Biol. 2015 Oct;248(5):909-17. doi: 10.1007/s00232-015-9800-2. Epub 2015 Apr 4.

PMID:
25840833
19.

Improved Specificity of Gene Electrotransfer to Skin Using pDNA Under the Control of Collagen Tissue-Specific Promoter.

Kos S, Tesic N, Kamensek U, Blagus T, Cemazar M, Kranjc S, Lavrencak J, Sersa G.

J Membr Biol. 2015 Oct;248(5):919-28. doi: 10.1007/s00232-015-9799-4. Epub 2015 Apr 4.

PMID:
25840832
20.

Adjuvant TNF-α therapy to electrochemotherapy with intravenous cisplatin in murine sarcoma exerts synergistic antitumor effectiveness.

Cemazar M, Todorovic V, Scancar J, Lampreht U, Stimac M, Kamensek U, Kranjc S, Coer A, Sersa G.

Radiol Oncol. 2015 Mar 3;49(1):32-40. doi: 10.1515/raon-2015-0005. eCollection 2015 Mar.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk